MMIC Advisory Board to help Victorian Manufacturing Innovate

10 October 2017

Monash University’s Medicines Manufacturing Innovation Centre (MMIC) announced the members of its Industry Advisory Board. Following the announcement an expert panel asked if pharmaceutical manufacturing is keeping pace with the advances of 21st century medicine. The event was hosted by the BioMelbourne Network.

Established this year in partnership with the Victorian Government, the Medicines Manufacturing Innovation Centre is focused on growing exports of medicines manufactured in Victoria. It supports pharmaceutical manufacturers and allied industries by facilitating the optimisation of processes, current and new product development and building supply of highly skilled, industry-ready, workforce candidates.

MMIC Director, Associate Professor Michelle McIntosh, said a major focus of the Centre was to provide trouble shooting support around analytical and formulation processes and to assist companies maintain competitiveness through innovation, while developing a skilled workforce to support the growing industry.

“We are working with numerous local manufacturers who are transitioning from exporting tablet and capsule based products into pharmaceuticals that involve advanced manufacturing capabilities ”

“Our aim is to be a compelling feature of the Victorian pharmaceutical ecosystem that makes Melbourne an attractive destination for international medical technology and pharmaceutical manufacturers.”

The Industry Advisory Board provides oversight and advice to MMIC. Their blend of skills embraces administration and business, government, large scale public research, pharmaceutical manufacturing, innovation and start-up.

“The Advisory Board bring together a wealth of knowledge and experience and are interested in developing a successful hub for the Victorian industry and a stronger pharmaceutical sector,” said Associate Professor Michelle McIntosh.

The Industry Advisory Board members are:

  • Lusia Guthrie
    Chairman of Clever Culture Systems Industry Advisory Committee ACVT and ARMI.
  • Rebecca Skinner
    Sector Strategy Manager, Advanced Manufacturing, DEDTJR
  • Dr David Sparling
    Vice President Legal and Corporate Development, IDT Australia
  • Dr Matthew Nussio
    Manager for Industry Partnerships at Monash University
  • Dr Andrew Hodder
    Vice President Operations, Mulgrave at Hospira
  • Dr Paul Savage
    Research Director of the Biomedical Manufacturing Program CSIRO
  • Dr Greg Ward
    Australia ‎Innovations Connection Facilitator at Deloitte Australia - AusIndustry
  • Dr Paul MacDonald
    Director Pharmaceutical Science, Pfizer Australia
  • Associate Professor Jan Tennent
    Chief Executive Officer, BioMedVic
  • Dr David Herd
    Director of Healthcare Environment, GlaxoSmithKline

The MMIC will facilitate training and industry based placements for students.